Bokkenheuser V D, Winter J, Dehazya P, Kelly W G
Appl Environ Microbiol. 1977 Nov;34(5):571-5. doi: 10.1128/aem.34.5.571-575.1977.
It has been known for a decade that human intestinal flora include organisms capable of 21-dehydroxylating corticoids. Yet the identity of the organisms synthesizing 21-dehydroxylase has remained unknown. Using diluted human feces, we determined the prevalence of colonies of 21-dehydroxylating organisms on a variety of media. Isolation from the medium of colonies with the highest prevalence yielded an obligate anaerobe capable of 21-dehydroxylating deoxycorticosterone and tetrahydrodeoxycorticosterone. This transformation could be carried out in a prereduced medium by the microbial culture alone or in an aerobic medium reduced by growth of Escherichia coli. The culture shares many characteristics with Eubacterium lentum, the neotype strain of which elaborated both 21-dehydroxylase and 3alpha-hydroxysteroid dehydrogenase.
十年前人们就已经知道,人类肠道菌群中包含能够对皮质类固醇进行21-脱羟基化的微生物。然而,合成21-脱羟基酶的微生物的具体身份一直不明。我们使用稀释的人类粪便,在多种培养基上测定了21-脱羟基化微生物菌落的流行率。从流行率最高的培养基中分离出的菌落得到了一种专性厌氧菌,它能够对脱氧皮质酮和四氢脱氧皮质酮进行21-脱羟基化。这种转化可以在预还原培养基中仅通过微生物培养来完成,或者在通过大肠杆菌生长而还原的需氧培养基中进行。该培养物与迟缓真杆菌有许多共同特征,迟缓真杆菌的新模式菌株同时产生了21-脱羟基酶和3α-羟基类固醇脱氢酶。